Campbell David Alan - Insider Non-Derivative Transactions at Janux Therapeutics, Inc. (JANX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 27, 2024, Campbell David Alan's relationship to Janux Therapeutics, Inc. (JANX) is Director,Officer (President and CEO), and currently has 313,097 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other JANX insiders.
Data Source: SEC.
Campbell David Alan - Insider Non-Derivative Transactions at JANX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 28, 2024 | Sell -- (Common Stock) | 795 | 47.84 | 307054 |
| Sep 28, 2024 | Sell -- (Common Stock) | 5248 | 46.86 | 307849 |
| Sep 28, 2024 | Sell -- (Common Stock) | 18957 | 46.09 | 313097 |